DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Martin M, Hurvitz SA, Chan D. et al.
Final results of NeoMONARCH: a phase 2 neoadjuvant study of abemaciclib in postmenopausal women with hormone receptor positive (HR+), HER2 negative breast cancer (BC) [abstract].
In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5–9; San Antonio, TX Philadelphia (PA): AACR
Cancer Res 2018;
78: Abstr.. PD5-01
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.